Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

NCT00936624 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 245

Last updated 2013-12-19

No results posted yet for this study

Summary

This study is a dose finding trial to assess the efficacy and safety of SOTB07 in persistent asthma.

Conditions

Interventions

DRUG

SOTB07

SOTB07 100mg

DRUG

SOTB07

SOTB07 200mg

DRUG

placebo

placebo

DRUG

montelukast

montelukast 10mg po, bid, 12week

Sponsors & Collaborators

  • SK Chemicals Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Sangheon Cho, professor · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00936624 on ClinicalTrials.gov